… identified significant molecular alterations in patients with COVID‐19 compared with uninfected
controls in this study. Our results refine the molecular view of COVID‐19 pathophysiology …

… immune system in the immunopathology of COVID-19. Indeed, the … response in patients
with COVID-19; in particular, we … drives the hyperinflammatory syndrome in severe COVID-19. …

… hyperinflammatory response in severely ill patients with COVID-19. This cascade of events
may … inflammatory markers in COVID-19-related complications. Different molecular pathways, …

… of COVID-19. However, there is limited evidence available as yet to delineate any
specific genetic markers. Dementia has been associated with an enhanced risk of COVID-19 …

… treatment of CoViD-19 is discussed. Taken together, the data of Diao et al could proffer
the first glimpse of immunopathology and possible immunotherapy for patients with CoViD-19. …

… in COVID-19 patients and its role in inflammatory processes, immunometabolism and
expression of TLRs, can make it a suitable molecular marker to assess the severity of COVID-19 …

… of severe and fatal COVID-19, and understand what … COVID-19 immunology research and
discuss definitive findings and remaining questions regarding our understanding of COVID-19 …

… and that dysfunction of multiple organs occurs in COVID-19 (17). The relationship among the
… consequences of COVID-19, we present a multiparameter tissue survey of fatal COVID-19. …

… severe COVID-19 and MIS-… genetic markers such as HLA class I alleles [59]. Accordingly,
the two SARS-CoV-2 caused diseases appear to be distinct with separate immunopathologies, …

… molecular pathway is proposed for COVID-19. The pathway is consistent with a broad range
of observed clinical features and biological markers … fronts of COVID-19 immunopathology. …